Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

377 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacodynamic and pharmacokinetic profile of RBx 343E48F0: a novel, long acting muscarinic receptor antagonist.
Gupta S, Malhotra S, Sinha S, Singh SK, Singh RK, Krishna S, Chhabra P, Chaira T, Kannayiram J, Sharma P, Aeron S, Kaur J, Kumar N, Sattigeri J, Shirumalla RK, Paliwal J, Dastidar SG, Cliffe IA, Ray A, Bhatnagar P. Gupta S, et al. Among authors: bhatnagar p. Eur J Pharmacol. 2011 May 11;658(2-3):219-28. doi: 10.1016/j.ejphar.2011.02.024. Epub 2011 Mar 1. Eur J Pharmacol. 2011. PMID: 21371471
RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes.
Singh S, Roy S, Sethi S, Benjamin B, Sundaram S, Khanna V, Kandalkar SR, Pal C, Kant R, Patra AK, Rayasam G, Mittra S, Saini KS, Paliwal J, Chugh A, Ahmed S, Sattigeri J, Cliff I, Ray A, Bansal VS, Bhatnagar PK, Davis JA. Singh S, et al. Eur J Pharmacol. 2011 Feb 10;652(1-3):157-63. doi: 10.1016/j.ejphar.2010.06.001. Epub 2010 Jun 9. Eur J Pharmacol. 2011. PMID: 20540938
RBx10080307, a dual EGFR/IGF-1R inhibitor for anticancer therapy.
Tandon R, Senthil V, Nithya D, Pamidiboina V, Kumar A, Malik S, Chaira T, Diwan M, Gupta P, Venkataramanan R, Malik R, Das B, Dastidar SG, Cliffe I, Ray A, Bhatnagar PK. Tandon R, et al. Among authors: bhatnagar pk. Eur J Pharmacol. 2013 Jul 5;711(1-3):19-26. doi: 10.1016/j.ejphar.2013.04.016. Epub 2013 Apr 29. Eur J Pharmacol. 2013. PMID: 23639757
A novel ketolide, RBx 14255, with activity against multidrug-resistant Streptococcus pneumoniae.
Raj VS, Barman TK, Kalia V, Purnapatre K, Dube S, G R, Bhateja P, Mathur T, Chaira T, Upadhyay DJ, Surase YB, Venkataramanan R, Chakrabarti A, Das B, Bhatnagar PK. Raj VS, et al. Among authors: bhatnagar pk. Antimicrob Agents Chemother. 2014 Aug;58(8):4283-9. doi: 10.1128/AAC.01589-13. Epub 2014 Feb 18. Antimicrob Agents Chemother. 2014. PMID: 24550341 Free PMC article.
Approaches towards the development of chimeric DPP4/ACE inhibitors for treating metabolic syndrome.
Sattigeri JA, Sethi S, Davis JA, Ahmed S, Rayasam GV, Jadhav BG, Chilla SM, Datta D, Gadhave A, Tulasi VK, Jain T, Voleti S, Benjamin B, Udupa S, Jain G, Singh Y, Srinivas K, Bansal VS, Ray A, Bhatnagar PK, Cliffe IA. Sattigeri JA, et al. Bioorg Med Chem Lett. 2017 Jun 1;27(11):2313-2318. doi: 10.1016/j.bmcl.2017.04.036. Epub 2017 Apr 13. Bioorg Med Chem Lett. 2017. PMID: 28442252
Cissampelos pareira Linn: Natural Source of Potent Antiviral Activity against All Four Dengue Virus Serotypes.
Sood R, Raut R, Tyagi P, Pareek PK, Barman TK, Singhal S, Shirumalla RK, Kanoje V, Subbarayan R, Rajerethinam R, Sharma N, Kanaujia A, Shukla G, Gupta YK, Katiyar CK, Bhatnagar PK, Upadhyay DJ, Swaminathan S, Khanna N. Sood R, et al. Among authors: bhatnagar pk. PLoS Negl Trop Dis. 2015 Dec 28;9(12):e0004255. doi: 10.1371/journal.pntd.0004255. eCollection 2015 Dec. PLoS Negl Trop Dis. 2015. PMID: 26709822 Free PMC article.
Novel FtsZ inhibitor with potent activity against Staphylococcus aureus.
Kumar M, Mathur T, Barman TK, Chaira T, Kumar R, Joshi V, Pandya M, Sharma L, Fujii K, Bandgar M, Jadhav B, Bambal R, Upadhyay D, Masuda N, Verma AK, Bhatnagar PK. Kumar M, et al. J Antimicrob Chemother. 2021 Oct 11;76(11):2867-2874. doi: 10.1093/jac/dkab270. J Antimicrob Chemother. 2021. PMID: 34383913
377 results